Online citations, reference lists, and bibliographies.
← Back to Search

Cytology Of Pleural And Peritoneal Lesions

S. Bose
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1097/JTO.0b013e31823e0667
Pleural Fluid Cytological Yield and Visceral Pleural Invasion in Patients with Epithelioid Malignant Pleural Mesothelioma
V. Pinelli (2012)
10.1309/AJCPHZ3CHO4HUWET
Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature.
William Wu (2013)
10.1111/cyt.12250
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed‐Type Malignant Mesothelioma: a secondary publication
A. Hjerpe (2015)
10.1002/cncy.20071
The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions
F. Hasteh (2010)
10.1002/dc.21146
Evidence‐based guidelines to optimize the selection of antibody panels in cytopathology: Pleural effusions with malignant epithelioid cells
Danielle E Westfall (2010)
10.1097/PAS.0000000000000529
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
H. Hwang (2016)
10.1016/S0002-9440(10)65749-5
Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation.
A. Matolcsy (1998)
10.5858/arpa.2012-0112-ra
The Separation of Benign and Malignant Mesothelial Proliferations
A. Churg (2012)
10.1002/dc.23271
Guidelines for the cytopathologic diagnosis of epithelioid and mixed‐type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
A. Hjerpe (2015)
10.1016/j.humpath.2013.07.021
Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.
Ross Taliano (2013)
10.1097/PAS.0000000000000394
BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
B. Sheffield (2015)
10.1111/cas.12769
Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue
T. Hida (2015)
10.1111/j.1365-2303.2007.00448.x
Cytomorphological and immunocytochemical study of non‐Hodgkin's lymphoma in pleural effusion and ascitic fluid
D. Das (2007)
10.1002/cncy.21392
Claudin‐4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology
V. Jo (2014)
10.1159/000327623
Combined Cytomorphologic and Immunophenotypic Analysis in the Diagnostic Workup of Lymphomatous Effusions
M. Bangerter (2001)
10.1002/cncy.21311
Kaposi sarcoma herpesvirus/human herpesvirus‐8–negative effusion‐based lymphoma: Report of 3 cases and review of the literature
J. Xiao (2013)
10.1182/BLOOD.V88.2.645.BLOODJOURNAL882645
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.
R. Nador (1996)
10.1155/2015/676894
Desmoplastic Small Round Cell Tumor, a “Floating Island” Pattern in Pleural Fluid Cytology: A Case Report and Review of the Literature
H. Zhu (2015)
10.1002/cncr.21282
Intraabdominal desmoplastic small round cell tumors
I. Hassan (2005)
Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities.
E. Cesarman (1996)
10.1002/dc.21800
Distinguishing benign from malignant mesothelial cells in effusions by Glut‐1, EMA, and Desmin expression: An evidence‐based approach
M. Kuperman (2013)
10.1002/dc.21303
The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma
E. Rakha (2010)
10.1002/dc.23298
An update on pleuro‐pulmonary cytopathology: Part i: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective
C. Bedrossian (2015)
10.1053/j.seminoncol.2014.12.026
Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
Marilia Rita Pinzone (2015)
10.1043/1543-2165-132.11.1716
A liquid concept--do classic preparations of body cavity fluid perform differently than ThinPrep cases? Observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology.
A. Moriarty (2008)
10.1002/cncr.10482
The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant mesothelioma
J. Hecht (2002)
10.4103/1742-6413.170726
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
A. Hjerpe (2015)
10.1093/qjmed/hcu232
Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management.
A. Klepfish (2015)
10.1056/NEJM199808133390705
Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.
D. Jones (1998)
10.5858/arpa.2015-0240-SA
New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
A. Churg (2016)
10.1002/(SICI)1097-0142(19980425)84:2<71::AID-CNCR1>3.0.CO;2-G
Cytologic features of sarcomas in fluids
M. A. Abadi (1998)
10.1002/DC.20698
Non‐gynecologic cytology on liquid‐based preparations: A morphologic review of facts and artifacts
R. Hoda (2007)
10.1002/dc.20938
Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis
E. Çakır (2009)
10.1159/000377697
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma
A. Hjerpe (2015)
10.1309/AJCPOATJ9L4GCGDA
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer.
T. Ito (2015)
10.4103/2277-9175.138888
Diagnostic value of claudin-4 marker in pleural and peritoneal effusion cytology: Does it differentiate between metastatic adenocarcinoma and reactive mesothelial cells?
N. Afsharmoghaddam (2014)
10.1111/j.1365-2559.2011.04036.x
Mesothelial markers in high‐grade breast carcinoma
E. Duhig (2011)
10.1378/CHEST.111.1.106
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
A. Renshaw (1997)
10.1043/1543-2165(2004)128<513:FABAOF>2.0.CO;2
Fluids--good and bad actors: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology.
A. Moriarty (2004)
10.1136/jclinpath-2012-201303
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers
D. Henderson (2013)
10.1002/cncy.21342
The diagnosis of malignant mesothelioma in effusion cytology
A. Paintal (2013)
10.1002/DC.20587
Diagnostic effects of prolonged storage on fresh effusion samples
Frances Manosca (2007)



Semantic Scholar Logo Some data provided by SemanticScholar